Regulatory mechanism of the arginine vasopressin-enhanced green fluorescent protein fusion gene expression in acute and chronic stress

Peptides

Volumn 30, Issue 9, 2009, Pages 1763-1770

  Suzuki, Hitoshi ^a   Kawasaki, Makoto ^a   Ohnishi, Hideo ^a   Nakamura, Toshitaka ^a   Ueta, Yoichi ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Arginine vasopressin; Corticotropin releasing hormone; GFP; Hypothalamo pituitary adrenal axis; Stress

Indexed keywords

ARGIPRESSIN; CORTICOSTERONE; CORTICOTROPIN RELEASING FACTOR; ENHANCED GREEN FLUORESCENT PROTEIN; LIPOPOLYSACCHARIDE; SODIUM CHLORIDE;

ACUTE STRESS; ADJUVANT ARTHRITIS; CHRONIC STRESS; FLUORESCENCE ANALYSIS; GENE EXPRESSION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNOHISTOCHEMISTRY; MAGNOCELLULAR NUCLEUS; MEDIAN EMINENCE; NEUROENDOCRINOLOGY; NOCICEPTION; NONHUMAN; OSMOSIS; PRIORITY JOURNAL; PROTEIN SECRETION; REGULATORY MECHANISM; REVIEW; SUPRAOPTIC NUCLEUS; THALAMUS MIDLINE NUCLEUS;

ANIMALS; ARGININE VASOPRESSIN; CORTICOTROPIN-RELEASING HORMONE; GENE EXPRESSION REGULATION; GREEN FLUORESCENT PROTEINS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; PITUITARY-ADRENAL SYSTEM; RECOMBINANT FUSION PROTEINS; STRESS, PHYSIOLOGICAL;

ANIMALIA; RATTUS;

EID: 67849090378     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2009.05.025     Document Type: Review

References (58)

1. Abercrombie E.D., and Jacobs B.L. Single-unit response of noradrenergic neurons in the locus coeruleus of freely moving cats. II. Adaptation to chronically presented stressful stimuli. J Neurosci 7 (1987) 2844-2848
2. Antoni F.A. Vasopressinergic control of pituitary adrenocorticotropin secretion comes of age. Front Neuroendocrinol 14 (1993) 76-122
3. Aston-Jones G., Ennis M., Pieribone V.A., Nickell W.T., and Shipley M.T. The brain nucleus locus coeruleus: restricted afferent control of a broad efferent network. Science 234 (1986) 734-737
4. Barberis C., and Tribollet E. Vasopressin and oxytocin receptors in the central nervous system. Crit Rev Neurobiol 10 (1996) 119-154
5. Berkowitz B.A., and Sherman S. Characterization of vasopressin analgesia. J Pharmacol Exp Ther 220 (1982) 329-334
6. Berson B.S., Berntson G.G., Zipf W., Torello M.W., and Kirk W.T. Vasopressin-induced antinociception: an investigation into its physiological and hormonal basis. Endocrinology 113 (1983) 337-343
7. Carlson D.E., Dornhorst A., Seif S.M., Robinson A.G., and Gann D.S. Vasopressin-dependent and -independent control of the release of adrenocorticotropin. Endocrinology 110 (1982) 680-682
8. Chikanza I.C., and Grossman A.S. Hypothalamic-pituitary-mediated immunomodulation: arginine vasopressin is a neuroendocrine immune mediator. Br J Rheumatol 37 (1998) 131-136
9. Chini B., and Fanelli F. Molecular basis of ligand binding and receptor activation in the oxytocin and vasopressin receptor family. Exp Physiol 85 (2000) [Spec No: 59S-66S]
10. Chowdrey H.S., Larsen P.J., Harbuz M.S., Jessop D.S., Aguilera G., Eckland D.J., et al. Evidence for arginine vasopressin as the primary activator of the HPA axis during adjuvant-induced arthritis. Br J Pharmacol 116 (1995) 2417-2424
11. Cunningham Jr. E.T., and Sawchenko P.E. Anatomical specificity of noradrenergic inputs to the paraventricular and supraoptic nuclei of the rat hypothalamus. J Comp Neurol 274 (1988) 60-76
12. Foote S.L., Bloom F.E., and Aston-Jones G. Nucleus locus ceruleus: new evidence of anatomical and physiological specificity. Physiol Rev 63 (1983) 844-914
13. Fujio T., Fujihara H., Shibata M., Yamada S., Onaka T., Tanaka K., et al. Exaggerated response of arginine vasopressin-enhanced green fluorescent protein fusion gene to salt loading without disturbance of body fluid homeostasis in rats. J Neuroendocrinol 18 (2006) 776-785
14. Guillon G., Derick S., Pena A., Cheng L.L., Stoev S., Seyer R., et al. The discovery of novel vasopressin V1b receptor ligands for pharmacological, functional and structural investigations. J Neuroendocrinol 16 (2004) 356-361
15. Harris G.W. Neural control of the pituitary gland. Physiol Rev 28 (1948) 139-179
16. Helmreich D.L., Itoi K., Lopez-Figueroa M.O., Akil H., and Watson S.J. Norepinephrine-induced CRH and AVP gene transcription within the hypothalamus: differential regulation by corticosterone. Brain Res Mol Brain Res 88 (2001) 62-73
17. Honda K., Negoro H., Dyball R.E., Higuchi T., and Takano S. The osmoreceptor complex in the rat: evidence for interactions between the supraoptic and other diencephalic nuclei. J Physiol 431 (1990) 225-241
18. Itoi K., Mouri T., Takahashi K., Murakami O., Imai Y., Sasaki S., et al. Suppression by glucocorticoid of the immunoreactivity of corticotropin-releasing factor and vasopressin in the paraventricular nucleus of rat hypothalamus. Neurosci Lett 73 (1987) 231-236
19. Jard S., Barberis C., Audigier S., and Tribollet E. Neurohypophyseal hormone receptor systems in brain and periphery. Prog Brain Res 72 (1987) 173-187
20. Kawasaki M., Onaka T., Saito J., Hashimoto H., Suzuki H., Otsubo H., et al. Effects of the short chain sugar acid 2-buten-4-olide on the hypothalamo-pituitary-adrenal axis in normal and adjuvant-induced arthritic rats. J Neuroendocrinol 19 (2007) 54-65
21. Kiss J.Z., Mezey E., and Skirboll L. Corticotropin-releasing factor-immunoreactive neurons of the paraventricular nucleus become vasopressin positive after adrenalectomy. Proc Natl Acad Sci USA 81 (1984) 1854-1858
22. Lavicky J., and Dunn A.J. Corticotropin-releasing factor stimulates catecholamine release in hypothalamus and prefrontal cortex in freely moving rats as assessed by microdialysis. J Neurochem 60 (1993) 602-612
23. Leng G., Brown C.H., and Russell J.A. Physiological pathways regulating the activity of magnocellular neurosecretory cells. Prog Neurobiol 57 (1999) 625-655
24. Lightman S.L., and Young III W.S. Corticotrophin-releasing factor, vasopressin and pro-opiomelanocortin mRNA responses to stress and opiates in the rat. J Physiol 403 (1988) 511-523
25. Lolait S.J., O'Carroll A.M., and Brownstein M.J. Molecular biology of vasopressin receptors. Ann NY Acad Sci 771 (1995) 273-292
26. Ma X.M., Levy A., and Lightman S.L. Emergence of an isolated arginine vasopressin (AVP) response to stress after repeated restraint: a study of both AVP and corticotropin-releasing hormone messenger ribonucleic acid (RNA) and heteronuclear RNA. Endocrinology 138 (1997) 4351-4357
27. Matsunaga W., Miyata S., Takamata A., Bun H., Nakashima T., and Kiyohara T. LPS-induced Fos expression in oxytocin and vasopressin neurons of the rat hypothalamus. Brain Res 858 (2000) 9-18
28. Munck A., Guyre P.M., and Holbrook N.J. Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocr Rev 5 (1984) 25-44
29. Oikawa R., Nasa Y., Ishii R., Kuwaki T., Tanoue A., Tsujimoto G., et al. Vasopressin V1A receptor enhances baroreflex via the central component of the reflex arc. Eur J Pharmacol 558 (2007) 144-150
30. Oliver G., and Schafer E.A. On the physiological action of extracts of pituitary body and certain other glandular organs: preliminary communication. J Physiol 18 (1895) 277-279
31. Palkovits M. Interconnections between the neuroendocrine hypothalamus and the central autonomic system. Geoffrey Harris Memorial Lecture, Kitakyushu, Japan, October 1998. Front Neuroendocrinol 20 (1999) 270-295
32. Passerin A.M., Cano G., Rabin B.S., Delano B.A., Napier J.L., and Sved A.F. Role of locus coeruleus in foot shock-evoked Fos expression in rat brain. Neuroscience 101 (2000) 1071-1082
33. Plotsky P.M. Facilitation of immunoreactive corticotropin-releasing factor secretion into the hypophysial-portal circulation after activation of catecholaminergic pathways or central norepinephrine injection. Endocrinology 121 (1987) 924-930
34. Rivest S., and Laflamme N. Neuronal activity and neuropeptide gene transcription in the brains of immune-challenged rats. J Neuroendocrinol 7 (1995) 501-525
35. Rivier C., and Vale W. Interaction of corticotropin-releasing factor and arginine vasopressin on adrenocorticotropin secretion in vivo. Endocrinology 113 (1983) 939-942
36. Rivier C., and Vale W. Modulation of stress-induced ACTH release by corticotropin-releasing factor, catecholamines and vasopressin. Nature 305 (1983) 325-327
37. Sawchenko P.E. Evidence for differential regulation of corticotropin-releasing factor and vasopressin immunoreactivities in parvocellular neurosecretory and autonomic-related projections of the paraventricular nucleus. Brain Res 437 (1987) 253-263
38. Sawchenko P.E., Swanson L.W., and Vale W.W. Co-expression of corticotropin-releasing factor and vasopressin immunoreactivity in parvocellular neurosecretory neurons of the adrenalectomized rat. Proc Natl Acad Sci USA 81 (1984) 1883-1887
39. Schafer E.A., and Vincent S. The physiological effects of extracts of the pituitary body. J Physiol 25 (1899) 87-97
40. Selye H. A syndrome produced by diverse nocuous agents. 1936. J Neuropsychiatry Clin Neurosci 10 (1998) 230-231
41. Selye H. The general adaptation syndrome and the diseases of adaptation. Practitioner 163 (1949) 393-405
42. Shibata M., Fujihara H., Suzuki H., Ozawa H., Kawata M., Dayanithi G., et al. Physiological studies of stress responses in the hypothalamus of vasopressin-enhanced green fluorescent protein transgenic rat. J Neuroendocrinol 19 (2007) 285-292
43. Spinedi E., Suescun M.O., Hadid R., Daneva T., and Gaillard R.C. Effects of gonadectomy and sex hormone therapy on the endotoxin-stimulated hypothalamo-pituitary-adrenal axis: evidence for a neuroendocrine-immunological sexual dimorphism. Endocrinology 131 (1992) 2430-2436
44. Steckler T., and Holsboer F. Corticotropin-releasing hormone receptor subtypes and emotion. Biol Psychiatry 46 (1999) 1480-1508
45. Suzuki H., Onaka T., Kasai M., Kawasaki M., Ohnishi H., Otsubo H., et al. Response of arginine vasopressin-enhanced green fluorescent protein fusion gene in the hypothalamus of adjuvant-induced arthritic rats. J Neuroendocrinol 21 (2009) 183-190
46. Tanoue A., Ito S., Honda K., Oshikawa S., Kitagawa Y., Koshimizu T.A., et al. The vasopressin V1b receptor critically regulates hypothalamic-pituitary-adrenal axis activity under both stress and resting conditions. J Clin Invest 113 (2004) 302-309
47. Ueta Y., Fujihara H., Serino R., Dayanithi G., Ozawa H., Matsuda K., et al. Transgenic expression of enhanced green fluorescent protein enables direct visualization for physiological studies of vasopressin neurons and isolated nerve terminals of the rat. Endocrinology 146 (2005) 406-413
48. Vale W., Spiess J., Rivier C., and Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 213 (1981) 1394-1397
49. Valentino R.J., Curtis A.L., Page M.E., Pavcovich L.A., and Florin-Lechner S.M. Activation of the locus ceruleus brain noradrenergic system during stress: circuitry, consequences, and regulation. Adv Pharmacol 42 (1998) 781-784
50. Valentino R.J., Foote S.L., and Aston-Jones G. Corticotropin-releasing factor activates noradrenergic neurons of the locus coeruleus. Brain Res 270 (1983) 363-367
51. Vandesande F., and Dierickx K. Identification of the vasopressin producing and of the oxytocin producing neurons in the hypothalamic magnocellular neurosecretory system of the rat. Cell Tissue Res 164 (1975) 153-162
52. Velden vd. Die nierenwirkung von hypophysenextrak-ten beim menshen. Berl Klin Wochenscgr 50 (1913) 2083-2086
53. Watts A.G. Glucocorticoid regulation of peptide genes in neuroendocrine CRH neurons: a complexity beyond negative feedback. Front Neuroendocrinol 26 (2005) 109-130
54. Whitnall M.H. Regulation of the hypothalamic corticotropin-releasing hormone neurosecretory system. Prog Neurobiol 40 (1993) 573-629
55. Widmaier E.P., Plotsky P.M., Sutton S.W., and Vale W.W. Regulation of corticotropin-releasing factor secretion in vitro by glucose. Am J Physiol 255 (1988) E287-E292
56. Xu S., Guo S., Jiang X., Yin Q., Umezawa T., and Hisamitsu T. Effect of indomethacin on the c-fos expression in AVP and TH neurons in rat brain induced by lipopolysaccharide. Brain Res 966 (2003) 13-18
57. Yasuda N., Greer M.A., Greer S.E., and Panton P. Studies on the site of action of vasopressin in inducing adrenocorticotropin secretion. Endocrinology 103 (1978) 906-911
58. Yu G., Chen H., Zhao W., Matta S.G., and Sharp B.M. Nicotine self-administration differentially regulates hypothalamic corticotropin-releasing factor and arginine vasopressin mRNAs and facilitates stress-induced neuronal activation. J Neurosci 28 (2008) 2773-2782